3-193289985-G-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_198505.4(ATP13A5):​c.2923C>T​(p.Leu975Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,694 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

ATP13A5
NM_198505.4 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.29
Variant links:
Genes affected
ATP13A5 (HGNC:31789): (ATPase 13A5) This gene encodes a member of the P5 subfamily of P-type transport ATPases. P-type ATPases form a large superfamily of cation and lipid pumps that transport inorganic cations and other substrates across cell membranes. P5 ATPases are localized to membranes of the endoplasmic reticulum (ER) and serve many important functions including transport of cargo proteins to the Golgi, glycosylation and cell wall biosynthesis, control of protein insertion orientation, 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) degradation, and sensitivity to unfolded protein response (UPR) activators. The encoded protein is organized into three cytoplasmic domains (A, P, and N) and two membrane-embedded domains (T and S). The N-domain binds ATP and serves as a built-in protein kinase, which phosphorylates the P-domain. The A-domain is an intrinsic protein phosphatase, which dephosphorylates the P-domain once during each catalytic cycle. [provided by RefSeq, Jul 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.23859307).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ATP13A5NM_198505.4 linkuse as main transcriptc.2923C>T p.Leu975Phe missense_variant 26/30 ENST00000342358.9 NP_940907.2 Q4VNC0
ATP13A5XM_047448075.1 linkuse as main transcriptc.1669C>T p.Leu557Phe missense_variant 16/20 XP_047304031.1
ATP13A5XM_017006305.1 linkuse as main transcriptc.1246C>T p.Leu416Phe missense_variant 13/17 XP_016861794.1
ATP13A5XM_011512770.3 linkuse as main transcriptc.2849-42C>T intron_variant XP_011511072.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ATP13A5ENST00000342358.9 linkuse as main transcriptc.2923C>T p.Leu975Phe missense_variant 26/301 NM_198505.4 ENSP00000341942.4 Q4VNC0
ATP13A5ENST00000495496.1 linkuse as main transcriptn.745C>T non_coding_transcript_exon_variant 8/125

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD3 exomes
AF:
0.00000399
AC:
1
AN:
250424
Hom.:
0
AF XY:
0.00000739
AC XY:
1
AN XY:
135352
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000463
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
6.85e-7
AC:
1
AN:
1460694
Hom.:
0
Cov.:
30
AF XY:
0.00000138
AC XY:
1
AN XY:
726670
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 22, 2023The c.2923C>T (p.L975F) alteration is located in exon 26 (coding exon 26) of the ATP13A5 gene. This alteration results from a C to T substitution at nucleotide position 2923, causing the leucine (L) at amino acid position 975 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.094
BayesDel_addAF
Benign
-0.011
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0053
T
Eigen
Benign
-0.080
Eigen_PC
Benign
-0.13
FATHMM_MKL
Benign
0.69
D
LIST_S2
Benign
0.82
T
M_CAP
Benign
0.024
T
MetaRNN
Benign
0.24
T
MetaSVM
Benign
-0.37
T
MutationAssessor
Benign
1.6
L
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-0.89
N
REVEL
Uncertain
0.36
Sift
Benign
0.49
T
Sift4G
Benign
0.32
T
Polyphen
0.95
P
Vest4
0.34
MutPred
0.47
Loss of glycosylation at P972 (P = 0.0098);
MVP
0.52
MPC
0.16
ClinPred
0.33
T
GERP RS
2.8
Varity_R
0.067
gMVP
0.49

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1422356927; hg19: chr3-193007774; API